Instem Reports that Leading R&D Organizations are Deploying Cyto Study Manager & Cutting-Edge Flow-Cytometric Regulatory Genetox Testing Techniques CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a ...
Archimed paid £203 million for Instem Instem reported revenue of £58.9m and pretax profit of $5.5m in 2022 Pre-clinical development will be a ‘growing focus’ Archimed has wrapped up its £203 million ...
Instem is excited to announce that it has closed on an acquisition of Strong Tower Solutions, a technology-enabled service provider with nearly 20 years of configuring and installing qualified, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results